This content is machine translated DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline Stroke prevention for atrial fibrillation 2025 Atrial fibrillation is the most important treatable risk factor for ischemic strokes in 2025 – and at the same time an area where precision makes all the difference. The major...…
View Post 8 min This content is machine translated New perspectives for clinics and research Ageing, cellular senescence and Parkinson’s disease Parkinson’s is one of the most common neurodegenerative diseases and continues to pose major challenges for neurology. It has long been clear that age is the decisive risk factor –...…
View Post 6 min This content is machine translated Migraine and vascular regulation CGRP-targeted migraine therapies for vascular risk patients Migraine is one of the most common neurological disorders and affects millions of people worldwide. With the development of CGRP-targeted therapies – monoclonal antibodies and Gepanten – the treatment of...…
View Post 6 min This content is machine translated Pediatric multiple sclerosis Early high efficacy as the key to improving prognosis Pediatric multiple sclerosis (POMS) is a rare but particularly challenging form of the disease. Children and adolescents with MS often experience more relapses, a greater lesion burden on MRI and...…
View Post 6 min This content is machine translated Diagnosis and treatment of neurological and psychiatric illnesses Precision Neurology Neuroscience has made a huge leap in knowledge in recent decades. New methods in genomics, epigenetics, proteomics, metabolomics, imaging and data integration make it possible to characterize diseases more precisely...…
View Post 8 min This content is machine translated Progressive multiple sclerosis New horizons: from BTK inhibitors to remyelination The progressive forms of multiple sclerosis – primary progressive MS (PPMS) and secondary progressive MS (SPMS) – have presented neurologists with particular challenges for decades. Unlike relapsing-remitting MS (RRMS), where...…
View Post 6 min This content is machine translated New evidence on genetics, pathophysiology and clinical significance Migraine with and without aura – two different entities? Migraine is one of the most common neurological disorders, and for decades it has been debated whether migraine with aura (MwA) and migraine without aura (MwoA) are merely different manifestations...…
View Post 5 min This content is machine translated An emerging interface with clinical relevance Lung cancer and neuroscience Lung cancer is still the leading cause of cancer-related mortality worldwide. In addition to established risk factors such as tobacco consumption and molecular alterations, the interaction between tumors and the...…
View Post 6 min This content is machine translated Past, present and future Biomarkers in schizophrenia Schizophrenia is one of the most complex and serious psychiatric disorders. Despite decades of research, many of its causes remain unexplained. In recent years, interest in biomarkers has grown considerably,...…
View Post 6 min This content is machine translated Current overview of evidence, mechanisms and clinical implications Apolipoprotein E and neuropsychiatric symptoms in neurocognitive disorders Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy, psychosis or behavioral disorders are among the most common concomitant symptoms of neurocognitive disorders and have just as strong an impact on...…
View Post 12 min This content is machine translated Parkinson's disease Individual therapy management for an optimized outcome – an update Parkinson’s disease is one of the most common neurodegenerative diseases, which manifests itself with motor symptoms such as slowness of movement (bradykinesia), tremors at rest (resting tremor) and muscle stiffness...… CME-Test
